Sisu Pharma
Latest round
- Seed
Last raised
- Oct 2020
Total raised
- $1.7M
Investors
- 1
About Sisu Pharma
Established in 2019 and based in US, Sisu Pharma operates as a medical drugs producer that focuses on cancer treatment. Dr. Sean O'Brien is the founder and CEO of the company. The company provides medical drugs for patients with prostate cancer. The company develops HI-LiTe platform. HI-LiTe platform includes heat shock factor 1 (HSF1) and hyperactivation in cancer.
Who invested in Sisu Pharma
1 investor across 1 round
See all investors in Sisu Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 19, 2020
Amount
$1.7M
Investors
Questions about Sisu Pharma
Who invested in Sisu Pharma?
Sisu Pharma has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sisu Pharma raised?
Sisu Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Sisu Pharma last raise money?
Sisu Pharma's most recent round on record is a Seed, in Oct 2020.
What does Sisu Pharma do?
Established in 2019 and based in US, Sisu Pharma operates as a medical drugs producer that focuses on cancer treatment.
Where is Sisu Pharma headquartered?
Sisu Pharma is headquartered in US.
Which VCs invest in companies like Sisu Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Sisu Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Sisu Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.